Search Results

Essential information needed to characterize the profile of a drug aimed at therapy.

October 2022 Novel Therapies for Cardiometabolic Disease: Recent Findings in Studies with Hormone Peptide-Derived Great success has been reached with therapies based on the GLP-1 receptor monoagonism; therefore, a logical

Nevertheless, researchers have a host of new technologies at their disposal to develop targeted therapies

September 2022 "Research on cancer therapies focuses on processes such as angiogenesis, cell signaling Moreover, the use of propranolol in combination therapies with other drugs has shown synergistic antitumor This review highlights the clinical trials in which propranolol is taking part as adjuvant therapy at

Oncology and Immunology Olfactory Receptors and Tumorigenesis: Implications for Diagnosis and Targeted Therapy The potential for precise tumor diagnosis and targeted therapy through therapeutic targeting of olfactory

GPCR News < GPCRs in Oncology and Immunology Comparison of infectious complications with BCMA-directed therapies in multiple myeloma Published date May 31, 2024 Abstract "B-cell-maturation-antigen (BCMA)-directed therapies analysis we evaluated infectious complications after BCMA-targeted chimeric-antigen-receptor T-cell therapy Comparing T-cell redirecting therapies, the incidence rate of severe infections was significantly lower

Immunology Metabolic crosstalk: Extracellular ATP and the tumor microenvironment in cancer progression and therapy